Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] How we treat primary central nervous system lymphoma
T Calimeri, S Steffanoni, F Gagliardi, A Chiara… - ESMO open, 2021 - Elsevier
Primary diffuse large B-cell (DLBCL) lymphoma of the central nervous system
(CNS)(PCNSL) is a new lymphoma entity, recognized by the 2017 WHO classification of …
(CNS)(PCNSL) is a new lymphoma entity, recognized by the 2017 WHO classification of …
Nanobiotechnology augmented cancer stem cell guided management of cancer: liquid-biopsy, imaging, and treatment
S Sun, Q Yang, D Jiang, Y Zhang - Journal of Nanobiotechnology, 2024 - Springer
Cancer stem cells (CSCs) represent both a key driving force and therapeutic target of
tumoral carcinogenesis, tumor evolution, progression, and recurrence. CSC-guided tumor …
tumoral carcinogenesis, tumor evolution, progression, and recurrence. CSC-guided tumor …
Advances in PET imaging of the CXCR4 receptor:[68Ga] Ga-PentixaFor
L Lindenberg, M Ahlman, F Lin, E Mena… - Seminars in nuclear …, 2024 - Elsevier
Highlights•[68 Ga] Ga-PentixaFor is a new molecular imaging agent targeting the CXC motif
chemokine ligand 12 (CXCL12)-Chemokine receptor-4 (CXCR4) chemokine axis.•CXCR4 is …
chemokine ligand 12 (CXCL12)-Chemokine receptor-4 (CXCR4) chemokine axis.•CXCR4 is …
Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals?
N Lepareur - Frontiers in medicine, 2022 - frontiersin.org
Over the last couple of decades, gallium-68 (68Ga) has gained a formidable interest for PET
molecular imaging of various conditions, from cancer to infection, through cardiac …
molecular imaging of various conditions, from cancer to infection, through cardiac …
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: a RANO review
Background The utility of liquid biopsies is well documented in several extracranial and
intracranial (brain/leptomeningeal metastases, gliomas) tumors. Methods The RANO …
intracranial (brain/leptomeningeal metastases, gliomas) tumors. Methods The RANO …
In vivo targeting of CXCR4—new horizons
M Schottelius, K Herrmann, C Lapa - Cancers, 2021 - mdpi.com
Simple Summary Beyond its pre-eminent role in the context of tumor cell growth as well as
metastasis, the CXC motif chemokine receptor 4 (CXCR4) is a key player in the …
metastasis, the CXC motif chemokine receptor 4 (CXCR4) is a key player in the …
CXCR4 PET/MRI for follow-up of gastric mucosa–associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication
ME Mayerhoefer, M Raderer, W Lamm… - Blood, The Journal …, 2022 - ashpublications.org
Posttreatment evaluation of gastric mucosa-associated lymphoid tissue (MALT) lymphoma
currently relies on esophagogastroduodenoscopy with histological assessment of biopsies …
currently relies on esophagogastroduodenoscopy with histological assessment of biopsies …
Development of a Rare Earth Nanoprobe Enables In Vivo Real-Time Detection of Sentinel Lymph Node Metastasis of Breast Cancer Using NIR-IIb Imaging
YY Zhu, L Song, YQ Zhang, WL Liu, WL Chen… - Cancer …, 2023 - aacrjournals.org
Sentinel lymph node (SLN) biopsy plays a critical role in axillary staging of breast cancer.
However, traditional SLN map** does not accurately discern the presence or absence of …
However, traditional SLN map** does not accurately discern the presence or absence of …
CXCR4 PET imaging of mantle cell lymphoma using [68Ga] Pentixafor: comparison with [18F] FDG-PET
For PET imaging of mantle cell lymphoma (MCL),[18F] FDG (2-deoxy-2-[18F] fluoro-D-
glucose) is the currently recommended radiotracer, although uptake is variable and bone …
glucose) is the currently recommended radiotracer, although uptake is variable and bone …
[HTML][HTML] Role of positron emission tomography in primary central nervous system lymphoma
Simple Summary Primary central nervous system lymphoma (PCNSL) is a rare but highly
aggressive lymphoma with increasing incidence in immunocompetent patients. To date, the …
aggressive lymphoma with increasing incidence in immunocompetent patients. To date, the …